XML 77 R63.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Summarized Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Mar. 04, 2021
Oct. 23, 2020
MYR        
Intangible assets:        
Deferred income taxes, net     $ (513)  
Other assets (and liabilities), net     (187)  
Total identifiable net assets     1,335  
Goodwill     226  
Total consideration     1,561  
MYR | In Process Research and Development        
Intangible assets:        
Acquired IPR&D     1,190  
MYR | Intangible asset – Hepcludex        
Intangible assets:        
Finite-lived intangible asset     $ 845  
Immunomedics, Inc.        
Business Acquisition [Line Items]        
Cash and cash equivalents       $ 726
Inventories $ 0 $ 294   946
Intangible assets:        
Deferred income taxes, net       (4,565)
Liability related to future royalties       (1,100)
Other assets (and liabilities), net       64
Total identifiable net assets       16,606
Goodwill       3,991
Total consideration       20,597
Immunomedics, Inc. | In Process Research and Development        
Intangible assets:        
Acquired IPR&D       15,760
Immunomedics, Inc. | Trodelvy        
Intangible assets:        
Finite-lived intangible asset       4,600
Immunomedics, Inc. | Licensing Agreements        
Intangible assets:        
Finite-lived intangible asset       $ 175